Oruka Therapeutics, Inc. · NASDAQ:ORKA

Kiselak Tomas sold 3,553,410 Oruka Therapeutics, Inc. shares (Form 4)

Traded Jul 1, 2026 · Filed Jul 1, 2026

On Jul 1, 2026, Kiselak Tomas (Director, 10% owner) sold 3,553,410 Oruka Therapeutics, Inc. shares at US$84.43 for US$300M, leaving 1,131,954 shares. Filed Jul 1, 2026 (Form 4).

Sold
3,553,410 shares
Price
US$84.43
Value
US$300M
Holding after
1,131,954 shares (held indirectly)
Trading plan
No
Role
Director, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 1, 2026Common StockConversion3,553,4104,685,364Indirect
Jul 1, 2026Common StockSale3,553,410US$84.431,131,954Indirect

Source

View original at SEC

Related